The Global Hyperthermia Treatment for Cancer Market is expected to exceed more than US$ 200 Million by 2028 at a CAGR of 6% in the given forecast period.
The spread of cancer disease is on a steady rise throughout the world. For research and development cancer is one of the most important platforms in medical science. Hyperthermia is a cancer treatment process where the body is exposed to 42 degree Celsius. Hyperthermia is used with other cancer therapy like Chemotherapy and radiation therapy. The growing number of specialists in the field of hyperthermia are making awareness among patients in regards to the utilization of hyperthermia to crush tumor cells and to build medicate ingestion in the objective cells by utilizing hyperthermia treatment in combination with chemotherapy.
There is a rising awareness in regards to the helpful impact of hyperthermia on different sorts of life-threatening infections and this, in turn, is probably going to expand the income development of the worldwide hyperthermia devices market. This quickly developing frequency of cancer everywhere throughout the world will prompt an expanded number of patients selecting cancer treatments. One of the important factor for growth of Hyperthermia Treatment for Cancer is its lesser side effect as compared to other therapies.
The global Hyperthermia Treatment for Cancer market is segregated on the basis of Type as Microwave Hyperthermia Device, Ultrasound Hyperthermia Device, Infrared Therapy Device, and Short-wave Therapy Device. Based on Application the global Hyperthermia Treatment for Cancer market is segmented in Research Institutes, Hospitals, Clinics, and Cancer Centers.
The global Hyperthermia Treatment for Cancer market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Hyperthermia Treatment for Cancer market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Pyrexar Medical, Oncothermia, Hydrosun GmbH, Perseon Medical, Omron Corporation, Sjn AG Yamamoto Vinita, Haifu Medical Technology Co.Ltd., Andromedic Sri, Celsius42 GmbH, Huahang, and others are among the major players in the global Hyperthermia Treatment for Cancer market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Hyperthermia Treatment for Cancer Market has been segmented as below:
Hyperthermia Treatment for Cancer Market, By Type
Hyperthermia Treatment for Cancer Market, By Application
Hyperthermia Treatment for Cancer Market, By Region
Hyperthermia Treatment for Cancer Market, By Company
The report covers:
Report Scope:
The global Hyperthermia Treatment for Cancer market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Hyperthermia Treatment for Cancer market share. Major industry players with significant revenue share include Pyrexar Medical, Oncothermia, Hydrosun GmbH, Perseon Medical, Omron Corporation, Sjn AG Yamamoto Vinita, Haifu Medical Technology Co.Ltd., Andromedic Sri, Celsius42 GmbH, Huahang, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Interventional Radiology Products Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. Hyperthermia Treatment for Cancer Market, By Type
5.1 Introduction
5.2 Microwave Hyperthermia Device
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Ultrasound Hyperthermia Device
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Infrared Therapy Device
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Short-wave Therapy Device
5.5.1 Market Overview
5.5.2 Market Size and Forecast
6. Hyperthermia Treatment for Cancer Market, By Application
6.1 Introduction
6.2 Research Institutes
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Hospitals
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Clinics
6.4.1 Market Overview
6.4.2 Market Size and Forecast
6.5 Cancer Centers
6.5.1 Market Overview
6.5.2 Market Size and Forecast
7. Hyperthermia Treatment for Cancer Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 North America Hyperthermia Treatment for Cancer, By Type
7.2.2 North America Hyperthermia Treatment for Cancer, By Application
7.3 Europe
7.3.1 Europe Hyperthermia Treatment for Cancer, By Type
7.3.2 Europe Hyperthermia Treatment for Cancer, By Application
7.4 Asia-Pacific
7.4.1 Asia-Pacific Hyperthermia Treatment for Cancer, By Type
7.4.2 Asia-Pacific Hyperthermia Treatment for Cancer, By Application
7.5 Rest of the World
7.5.1 Rest of the World Hyperthermia Treatment for Cancer, By Type
7.5.2 Rest of the World Hyperthermia Treatment for Cancer, By Application
8. Competitive Insights
8.1 Key Insights
8.2 Company Market Share Analysis
8.3 Strategic Outlook
8.3.1 Mergers & Acquisitions
8.3.2 New Product Development
8.3.3 Portfolio/Production Capacity Expansions
8.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
8.3.5 Others
9. Company Profiles
9.1 Pyrexar Medical
9.1.1 Company Overview
9.1.2 Product/Service Landscape
9.1.3 Financial Overview
9.1.4 Recent Developments
9.2 Oncothermia
9.2.1 Company Overview
9.2.2 Product/Service Landscape
9.2.3 Financial Overview
9.2.4 Recent Developments
9.3 Hydrosun GmbH
9.3.1 Company Overview
9.3.2 Product/Service Landscape
9.3.3 Financial Overview
9.3.4 Recent Developments
9.4 Perseon Medical
9.4.1 Company Overview
9.4.2 Product/Service Landscape
9.4.3 Financial Overview
9.4.4 Recent Developments
9.5 Omron Corporation
9.5.1 Company Overview
9.5.2 Product/Service Landscape
9.5.3 Financial Overview
9.5.4 Recent Developments
9.6 Sjn AG Yamamoto Vinita
9.6.1 Company Overview
9.6.2 Product/Service Landscape
9.6.3 Financial Overview
9.6.4 Recent Developments
9.7 Haifu Medical Technology Co.Ltd.
9.7.1 Company Overview
9.7.2 Product/Service Landscape
9.7.3 Financial Overview
9.7.4 Recent Developments
9.8 Andromedic Sri
9.8.1 Company Overview
9.8.2 Product/Service Landscape
9.8.3 Financial Overview
9.8.4 Recent Developments
9.9 Celsius42 GmbH
9.9.1 Company Overview
9.9.2 Product/Service Landscape
9.9.3 Financial Overview
9.9.4 Recent Developments
9.10 Huahang
9.10.1 Company Overview
9.10.2 Product/Service Landscape
9.10.3 Financial Overview
9.10.4 Recent Developments
The Hyperthermia Treatment for Cancer Market has been segmented as below:
Hyperthermia Treatment for Cancer Market, By Type
Hyperthermia Treatment for Cancer Market, By Application
Hyperthermia Treatment for Cancer Market, By Region
Hyperthermia Treatment for Cancer Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
